Treatment of Paget's disease of bone

被引：0
作者：
Arias M, Garcia [1 ]
Eslava A, Torrijos [2 ]
机构：
[1] HU La Paz, Serv Reumatol, Paseo Castellana 261, Madrid 28046, Spain
[2] HU La Paz, Serv Reumatol, Unidad Metab Osea, Madrid, Spain
来源：
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL | 2011年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 40
页数：6
相关论文
共 42 条
[1]   A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg [J].
Abelson, Abby .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) :695-705
[2]  
Aguado P, 2006, ENFERMEDAD DE PAGET, P103
[3]  
ALEXANDRE CM, 1983, CLIN ORTHOP RELAT R, V174, P193
[4]  
Anderson DC, 1988, ADV ENDOCRINOL, V6, P156
[5]   Improvement of pagetic bone lesions with risedronate treatment: A radiologic study [J].
Brown, JP ;
Chines, AA ;
Myers, WR ;
Eusebio, RA ;
Ritter-Hrncirik, C ;
Hayes, CW .
BONE, 2000, 26 (03) :263-267
[6]   Risedronate, a highly effective, short-term oral treatment for Paget's disease: A dose-response study [J].
Brown, JP ;
Hosking, DJ ;
Ste-Marie, LG ;
Johnston, CC ;
Reginster, JY ;
Ryan, WG ;
Johnson, TD ;
Bekker, PJ .
CALCIFIED TISSUE INTERNATIONAL, 1999, 64 (02) :93-99
[7]  
Buckler H, 1999, BONE, V8, P1
[8]  
Carbonell Abello J., 1992, Revista Espanola de Reumatologia, V19, P111
[9]  
Cobo T, 2003, REV ESP REUMATOL, V30, P288
[10]   Brief report: Recombinant osteoprotegerin for juvenile Paget's disease [J].
Cundy, T ;
Davidson, J ;
Rutland, MD ;
Stewart, C ;
DePaoli, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09) :918-923
12345